1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Vascular Dementias Global Clinical Trials Review, H2, 2014

Vascular Dementias Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Vascular Dementias Global Clinical Trials Review, H2, 2014" provides data on the Vascular Dementias clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Vascular Dementias. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Vascular Dementias. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Vascular Dementias Global Clinical Trials Review, H2, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Vascular Dementias 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Countries: Proportion of Vascular Dementias to Central Nervous System Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Vascular Dementias to Central Nervous System Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Vascular Dementias 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Vascular Dementias Therapeutics Clinical Trials 28
Prominent Drugs 29
Clinical Trial Profiles 30
Clinical Trial Overview of Top Companies 30
Pfizer Inc. 30
Clinical Trial Overview of Pfizer Inc. 30
Johnson and Johnson 31
Clinical Trial Overview of Johnson and Johnson 31
Novartis AG 32
Clinical Trial Overview of Novartis AG 32
Janssen-Cilag A.G. 33
Clinical Trial Overview of Janssen-Cilag A.G. 33
Golgi Pharmaceuticals Ltd 34
Clinical Trial Overview of Golgi Pharmaceuticals Ltd 34
EVER Neuro Pharma GmbH 35
Clinical Trial Overview of EVER Neuro Pharma GmbH 35
Eisai Co., Ltd. 36
Clinical Trial Overview of Eisai Co., Ltd. 36
Dr. Willmar Schwabe Pharmaceuticals 37
Clinical Trial Overview of Dr. Willmar Schwabe Pharmaceuticals 37
Diaxonhit S.A. 38
Clinical Trial Overview of Diaxonhit S.A. 38
Clinical Trial Overview of Top Institutes / Government 39
University of Pennsylvania 39
Clinical Trial Overview of University of Pennsylvania 39
Ministry of Education, Culture, Sports, Science and Technology 40
Clinical Trial Overview of Ministry of Education, Culture, Sports, Science and Technology 40
Radboud University 41
Clinical Trial Overview of Radboud University 41
University of Pittsburgh 42
Clinical Trial Overview of University of Pittsburgh 42
Cardiff University 43
Clinical Trial Overview of Cardiff University 43
University of Western Sydney 44
Clinical Trial Overview of University of Western Sydney 44
Chang Gung Memorial Foundation 45
Clinical Trial Overview of Chang Gung Memorial Foundation 45
VU University Medical Center 46
Clinical Trial Overview of VU University Medical Center 46
Samsung Medical Center 47
Clinical Trial Overview of Samsung Medical Center 47
The Sheba Medical Center 48
Clinical Trial Overview of The Sheba Medical Center 48
Five Key Clinical Profiles 49
Appendix 67
Abbreviations 67
Definitions 67
Research Methodology 68
Secondary Research 68
About GlobalData 69
Contact Us 69
Disclaimer 69
Source 69

List of Tables
Vascular Dementias Therapeutics, Global, Clinical Trials by Region, 2014* 7
Vascular Dementias Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Vascular Dementias Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Vascular Dementias Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Vascular Dementias Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Vascular Dementias Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Vascular Dementias Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Proportion of Vascular Dementias to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 14
Vascular Dementias Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Vascular Dementias Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Vascular Dementias to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 17
Vascular Dementias Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Vascular Dementias Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19
Vascular Dementias Therapeutics, Global, Clinical Trials by Phase, 2014* 20
Vascular Dementias Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 21
Vascular Dementias Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Vascular Dementias Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
Vascular Dementias Therapeutics, Global, Terminated Clinical Trials, 2014* 24
Vascular Dementias Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Vascular Dementias Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 26
Vascular Dementias Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27
Vascular Dementias Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
Vascular Dementias Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
Vascular Dementias Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 30
Vascular Dementias Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson and Johnson, 2014* 31
Vascular Dementias Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 32
Vascular Dementias Therapeutics Clinical Trials Market, Global, Clinical Trials by Janssen-Cilag A.G., 2014* 33
Vascular Dementias Therapeutics Clinical Trials Market, Global, Clinical Trials by Golgi Pharmaceuticals Ltd, 2014* 34
Vascular Dementias Therapeutics Clinical Trials Market, Global, Clinical Trials by EVER Neuro Pharma GmbH, 2014* 35
Vascular Dementias Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2014* 36
Vascular Dementias Therapeutics Clinical Trials Market, Global, Clinical Trials by Dr. Willmar Schwabe Pharmaceuticals, 2014* 37
Vascular Dementias Therapeutics Clinical Trials Market, Global, Clinical Trials by Diaxonhit S.A., 2014* 38
Vascular Dementias Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pennsylvania, 2014* 39
Vascular Dementias Therapeutics Clinical Trials Market, Global, Clinical Trials by Ministry of Education, Culture, Sports, Science and Technology, 2014* 40
Vascular Dementias Therapeutics Clinical Trials Market, Global, Clinical Trials by Radboud University, 2014* 41
Vascular Dementias Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2014* 42
Vascular Dementias Therapeutics Clinical Trials Market, Global, Clinical Trials by Cardiff University, 2014* 43
Vascular Dementias Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Western Sydney, 2014* 44
Vascular Dementias Therapeutics Clinical Trials Market, Global, Clinical Trials by Chang Gung Memorial Foundation, 2014* 45
Vascular Dementias Therapeutics Clinical Trials Market, Global, Clinical Trials by VU University Medical Center, 2014* 46
Vascular Dementias Therapeutics Clinical Trials Market, Global, Clinical Trials by Samsung Medical Center, 2014* 47
Vascular Dementias Therapeutics Clinical Trials Market, Global, Clinical Trials by The Sheba Medical Center, 2014* 48

List of Figures
Vascular Dementias Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Vascular Dementias Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Vascular Dementias Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Vascular Dementias Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Vascular Dementias Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Vascular Dementias Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Proportion of Vascular Dementias to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 14
Vascular Dementias Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Vascular Dementias Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Vascular Dementias to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 17
Vascular Dementias Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Vascular Dementias Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19
Vascular Dementias Therapeutics, Global, Clinical Trials by Phase (%), 2014* 20
Vascular Dementias Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 21
Vascular Dementias Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Vascular Dementias Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
Vascular Dementias Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Vascular Dementias Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 26
Vascular Dementias Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27
Vascular Dementias Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
Vascular Dementias Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
GlobalData Methodology 68

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.